The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pleural Effusions Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Pleural effusions treatment includes medical procedures and interventions used to manage the accumulation of fluid in the pleural space around the lungs.
The global Pleural Effusions Treatment market size is expected to reach US$ 2474.1 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pleural Effusions Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pleural Effusions Treatment market. Thoracentesis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pleurodesis segment is estimated at % CAGR for the next seven-year period.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pleural Effusions Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pleural Effusions Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pleural Effusions Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pleural Effusions Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pleural Effusions Treatment covered in this report include B. Braun, Nouvag, Oakworks Medical, Heyer Medical, Smith Medical, Biometrix, Maxer, Redax and Bicakcilar, etc.
The global Pleural Effusions Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Global Pleural Effusions Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pleural Effusions Treatment market, Segment by Type:
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Global Pleural Effusions Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pleural Effusions Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pleural effusions treatment includes medical procedures and interventions used to manage the accumulation of fluid in the pleural space around the lungs.
The global Pleural Effusions Treatment market size is expected to reach US$ 2474.1 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pleural Effusions Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Pleural Effusions Treatment market. Thoracentesis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pleurodesis segment is estimated at % CAGR for the next seven-year period.
The market for pleural effusions treatment is driven by the demand for effective and minimally invasive procedures to drain and manage pleural fluid build-up. The market's growth is also influenced by the increasing prevalence of pleural effusions in various medical conditions, such as congestive heart failure and cancer.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pleural Effusions Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pleural Effusions Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pleural Effusions Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pleural Effusions Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pleural Effusions Treatment covered in this report include B. Braun, Nouvag, Oakworks Medical, Heyer Medical, Smith Medical, Biometrix, Maxer, Redax and Bicakcilar, etc.
The global Pleural Effusions Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
B. Braun
Nouvag
Oakworks Medical
Heyer Medical
Smith Medical
Biometrix
Maxer
Redax
Bicakcilar
Grena
Shyndec Pharmaceutical
Lepu Medical
Balance Medical
Global Pleural Effusions Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pleural Effusions Treatment market, Segment by Type:
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Global Pleural Effusions Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pleural Effusions Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pleural Effusions Treatment
1.1 Pleural Effusions Treatment Market Overview
1.1.1 Pleural Effusions Treatment Product Scope
1.1.2 Pleural Effusions Treatment Market Status and Outlook
1.2 Global Pleural Effusions Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pleural Effusions Treatment Market Size by Region (2018-2029)
1.4 Global Pleural Effusions Treatment Historic Market Size by Region (2018-2023)
1.5 Global Pleural Effusions Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pleural Effusions Treatment Market Size (2018-2029)
1.6.1 North America Pleural Effusions Treatment Market Size (2018-2029)
1.6.2 Europe Pleural Effusions Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Pleural Effusions Treatment Market Size (2018-2029)
1.6.4 Latin America Pleural Effusions Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Pleural Effusions Treatment Market Size (2018-2029)
2 Pleural Effusions Treatment Market by Type
2.1 Introduction
2.1.1 Thoracentesis
2.1.2 Pleurodesis
2.1.3 Pleuroperitoneal Shunt
2.2 Global Pleural Effusions Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pleural Effusions Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Pleural Effusions Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pleural Effusions Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pleural Effusions Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pleural Effusions Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pleural Effusions Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pleural Effusions Treatment Revenue Breakdown by Type (2018-2029)
3 Pleural Effusions Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pleural Effusions Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pleural Effusions Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Pleural Effusions Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pleural Effusions Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pleural Effusions Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pleural Effusions Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pleural Effusions Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pleural Effusions Treatment Revenue Breakdown by Application (2018-2029)
4 Pleural Effusions Treatment Competition Analysis by Players
4.1 Global Pleural Effusions Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pleural Effusions Treatment as of 2022)
4.3 Date of Key Players Enter into Pleural Effusions Treatment Market
4.4 Global Top Players Pleural Effusions Treatment Headquarters and Area Served
4.5 Key Players Pleural Effusions Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Pleural Effusions Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 B. Braun
5.1.1 B. Braun Profile
5.1.2 B. Braun Main Business
5.1.3 B. Braun Pleural Effusions Treatment Products, Services and Solutions
5.1.4 B. Braun Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 B. Braun Recent Developments
5.2 Nouvag
5.2.1 Nouvag Profile
5.2.2 Nouvag Main Business
5.2.3 Nouvag Pleural Effusions Treatment Products, Services and Solutions
5.2.4 Nouvag Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Nouvag Recent Developments
5.3 Oakworks Medical
5.3.1 Oakworks Medical Profile
5.3.2 Oakworks Medical Main Business
5.3.3 Oakworks Medical Pleural Effusions Treatment Products, Services and Solutions
5.3.4 Oakworks Medical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Heyer Medical Recent Developments
5.4 Heyer Medical
5.4.1 Heyer Medical Profile
5.4.2 Heyer Medical Main Business
5.4.3 Heyer Medical Pleural Effusions Treatment Products, Services and Solutions
5.4.4 Heyer Medical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Heyer Medical Recent Developments
5.5 Smith Medical
5.5.1 Smith Medical Profile
5.5.2 Smith Medical Main Business
5.5.3 Smith Medical Pleural Effusions Treatment Products, Services and Solutions
5.5.4 Smith Medical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Smith Medical Recent Developments
5.6 Biometrix
5.6.1 Biometrix Profile
5.6.2 Biometrix Main Business
5.6.3 Biometrix Pleural Effusions Treatment Products, Services and Solutions
5.6.4 Biometrix Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Biometrix Recent Developments
5.7 Maxer
5.7.1 Maxer Profile
5.7.2 Maxer Main Business
5.7.3 Maxer Pleural Effusions Treatment Products, Services and Solutions
5.7.4 Maxer Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Maxer Recent Developments
5.8 Redax
5.8.1 Redax Profile
5.8.2 Redax Main Business
5.8.3 Redax Pleural Effusions Treatment Products, Services and Solutions
5.8.4 Redax Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Redax Recent Developments
5.9 Bicakcilar
5.9.1 Bicakcilar Profile
5.9.2 Bicakcilar Main Business
5.9.3 Bicakcilar Pleural Effusions Treatment Products, Services and Solutions
5.9.4 Bicakcilar Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Bicakcilar Recent Developments
5.10 Grena
5.10.1 Grena Profile
5.10.2 Grena Main Business
5.10.3 Grena Pleural Effusions Treatment Products, Services and Solutions
5.10.4 Grena Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Grena Recent Developments
5.11 Shyndec Pharmaceutical
5.11.1 Shyndec Pharmaceutical Profile
5.11.2 Shyndec Pharmaceutical Main Business
5.11.3 Shyndec Pharmaceutical Pleural Effusions Treatment Products, Services and Solutions
5.11.4 Shyndec Pharmaceutical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Shyndec Pharmaceutical Recent Developments
5.12 Lepu Medical
5.12.1 Lepu Medical Profile
5.12.2 Lepu Medical Main Business
5.12.3 Lepu Medical Pleural Effusions Treatment Products, Services and Solutions
5.12.4 Lepu Medical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Lepu Medical Recent Developments
5.13 Balance Medical
5.13.1 Balance Medical Profile
5.13.2 Balance Medical Main Business
5.13.3 Balance Medical Pleural Effusions Treatment Products, Services and Solutions
5.13.4 Balance Medical Pleural Effusions Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Balance Medical Recent Developments
6 North America
6.1 North America Pleural Effusions Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Pleural Effusions Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pleural Effusions Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pleural Effusions Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pleural Effusions Treatment Market Dynamics
11.1 Pleural Effusions Treatment Industry Trends
11.2 Pleural Effusions Treatment Market Drivers
11.3 Pleural Effusions Treatment Market Challenges
11.4 Pleural Effusions Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
